PELICAN DIAGNOSTICS LTD

Company Registration Number:
14600847 (England and Wales)

Unaudited statutory accounts for the year ended 31 January 2024

Period of accounts

Start date: 18 January 2023

End date: 31 January 2024

PELICAN DIAGNOSTICS LTD

Contents of the Financial Statements

for the Period Ended 31 January 2024

Profit and loss
Balance sheet
Additional notes
Balance sheet notes

PELICAN DIAGNOSTICS LTD

Profit And Loss Account

for the Period Ended 31 January 2024

2024


£
Turnover: 16,996
Cost of sales: ( 1,434 )
Gross profit(or loss): 15,562
Distribution costs: 0
Administrative expenses: ( 29,320 )
Other operating income: 0
Operating profit(or loss): (13,758)
Interest receivable and similar income: 0
Interest payable and similar charges: 0
Profit(or loss) before tax: (13,758)
Profit(or loss) for the financial year: (13,758)

PELICAN DIAGNOSTICS LTD

Balance sheet

As at 31 January 2024

Notes 2024


£
Called up share capital not paid: 0
Fixed assets
Intangible assets:   0
Tangible assets: 3 22,650
Investments:   0
Total fixed assets: 22,650
Current assets
Stocks:   0
Debtors:   0
Cash at bank and in hand: 439
Investments:   0
Total current assets: 439
Creditors: amounts falling due within one year: 4 ( 4,201 )
Net current assets (liabilities): (3,762)
Total assets less current liabilities: 18,888
Creditors: amounts falling due after more than one year:   0
Provision for liabilities: ( 1,000 )
Accruals and deferred income: 0
Total net assets (liabilities): 17,888
Capital and reserves
Called up share capital: 17,888
Share premium account: 0
Other reserves: 0
Profit and loss account: 0
Total Shareholders' funds: 17,888

The notes form part of these financial statements

PELICAN DIAGNOSTICS LTD

Balance sheet statements

For the year ending 31 January 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 31 October 2024
and signed on behalf of the board by:

Name: Patryk Petrus
Status: Director

The notes form part of these financial statements

PELICAN DIAGNOSTICS LTD

Notes to the Financial Statements

for the Period Ended 31 January 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Financial Reporting Standard 101

    Turnover policy

    Turnover represent all income derived from repair services we provide

PELICAN DIAGNOSTICS LTD

Notes to the Financial Statements

for the Period Ended 31 January 2024

  • 2. Employees

    2024
    Average number of employees during the period 2

PELICAN DIAGNOSTICS LTD

Notes to the Financial Statements

for the Period Ended 31 January 2024

3. Tangible assets

Land & buildings Plant & machinery Fixtures & fittings Office equipment Motor vehicles Total
Cost £ £ £ £ £ £
Additions 22,650 22,650
Disposals
Revaluations
Transfers
At 31 January 2024 22,650 22,650
Depreciation
Charge for year 0 0
On disposals
Other adjustments
At 31 January 2024 0 0
Net book value
At 31 January 2024 22,650 22,650

PELICAN DIAGNOSTICS LTD

Notes to the Financial Statements

for the Period Ended 31 January 2024

4. Creditors: amounts falling due within one year note

2024
£
Bank loans and overdrafts 4,201
Total 4,201